Schnitzbauer, AA, Filmann, N, Adam, R, Bachellier, P, Bechstein, WO, Becker, T, Bhoori, S, Bilbao, I, Brockmann, J, Burra, P, Chazoullieres, O, Cillo, U, Colledan, M, Duvoux, C, Ganten, TM, Gugenheim, J, Heise, M, van Hoek, B, Jamieson, N, de Jong, KP, Klein, CG, Klempnauer, J, Kneteman, N, Lerut, J
, Makisalo, H, Mazzaferro, V, Mirza, DF, Nadalin, S, Neuhaus, P, Pageaux, G-P, Pinna, AD, Pirenne, J, Pratschke, J, Powel, J, Rentsch, M, Rizell, M, Rossi, G, Rostaing, L, Roy, A, Scholz, T, Settmacher, U, Soliman, T, Strasser, S, Soderdahl, G, Troisi, RI, Sanchez Turrion, V, Schlitt, HJ & Geissler, EK 2020, '
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors',
Annals of Surgery, vol. 272, no. 5, pp. 855-862.
https://doi.org/10.1097/SLA.0000000000004280